This inventor holds 1 USPTO granted patent. Top assignee: Charité – Universitätsmedizin Berlin. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Nese Cakmak-Görür: Innovator in Gene Therapy
Introduction
Nese Cakmak-Görür is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of gene therapy, particularly in the development of innovative treatments for various medical conditions. Her work is characterized by a commitment to advancing scientific knowledge and improving patient outcomes.
Latest Patents
Nese holds a patent for a groundbreaking invention titled "CD5 Specific T Cell Receptor Cell or Gene Therapy." This patent represents a significant advancement in the field of immunotherapy, showcasing her expertise and dedication to medical innovation. She has 1 patent to her name, reflecting her impactful contributions to the scientific community.
Career Highlights
Nese Cakmak-Görür is affiliated with Charité – Universitätsmedizin Berlin, one of Europe's largest university hospitals. Her role at this prestigious institution allows her to collaborate with leading researchers and clinicians in the field. Nese's career is marked by her focus on developing therapies that harness the power of the immune system to combat diseases.
Collaborations
Throughout her career, Nese has worked alongside esteemed colleagues, including Antonio Pezzutto and Thomas Blankenstein. These collaborations have enriched her research and contributed to the advancement of gene therapy techniques.
Conclusion
Nese Cakmak-Görür is a trailblazer in the field of gene therapy, with a focus on innovative treatments that leverage the immune system. Her contributions, including her patent and collaborations, highlight her commitment to advancing medical science. Nese's work continues to inspire future innovations in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
